Aureka Biotechnologies, Inc. is a biotech startup with a mission to democratize the pharmaceutical industry by focusing on immunotherapeutic discovery. Their integrated digital biology and AI solutions empower partners to efficiently bring new medicines to patients. By integrating microfluidics, synthetic biology, and AI, Aureka has developed a powerful drug discovery platform that accelerates the path from concept to market. The company was founded in 2023 and is headquartered in the United States. Their latest milestone includes a $10.00M Seed Round investment led by K2VC and NRL Capital on 25 June 2023. Aureka Biotechnologies, with their focus on therapeutic design and innovative approach to drug discovery, presents an exciting opportunity for investors in the biotechnology and pharmaceutical sectors.
No recent news or press coverage available for Aureka Biotechnologies, Inc..